DNM2 and schizophrenia: Very recently, Michael Maes, in collaboration with our laboratory, reported increased plasma level of antibodies against Gram-negative bacteria, paracellular tight and adherens junction, transcellular cytoskeletal proteins, gut vascular barrier and blood brain barrier proteins in patients with deficit schizophrenia.